Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124703593 | 12470359 | 3 | F | 20160502 | 20160823 | 20160616 | 20160826 | EXP | DE-ROCHE-1772143 | ROCHE | 0.00 | F | Y | 54.00000 | KG | 20160826 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124703593 | 12470359 | 1 | PS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | DATE OF LAST DOSE PRIOR TO SAE 13/MAY/2016 | Y | 125409 | 420 | MG | SOLUTION FOR INFUSION | Q3W | |||||
| 124703593 | 12470359 | 2 | SS | Pertuzumab | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | Y | 125409 | SOLUTION FOR INFUSION | |||||||||
| 124703593 | 12470359 | 3 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | 330 MG?DATE OF LAST DOSE PRIOR TO SAE 13/MAY/2016 | Y | 103792 | 6 | MG/KG | SOLUTION FOR INFUSION | TIW | |||||
| 124703593 | 12470359 | 4 | SS | Trastuzumab | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | Y | 103792 | SOLUTION FOR INFUSION | |||||||||
| 124703593 | 12470359 | 5 | C | NOVAMINSULFON | METAMIZOLE | 1 | Unknown | 0 | 500 | MG | |||||||||
| 124703593 | 12470359 | 6 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | 40 | MG | |||||||||
| 124703593 | 12470359 | 7 | C | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Unknown | 0 | 2 | G | |||||||||
| 124703593 | 12470359 | 8 | C | ROCEPHIN | CEFTRIAXONE SODIUM | 1 | Intravenous (not otherwise specified) | 0 | 2 | MG | |||||||||
| 124703593 | 12470359 | 9 | C | STRIVERDI RESPIMAT | OLODATEROL HYDROCHLORIDE | 1 | Unknown | 0 | 2.5 | UG | |||||||||
| 124703593 | 12470359 | 10 | C | TILIDIN | NALOXONE HYDROCHLORIDETILIDINE HYDROCHLORIDE | 1 | Unknown | 50/4 | 0 | 50 | MG | ||||||||
| 124703593 | 12470359 | 11 | C | TOREM | TORSEMIDE | 1 | Unknown | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124703593 | 12470359 | 1 | HER-2 positive breast cancer |
| 124703593 | 12470359 | 3 | HER-2 positive breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124703593 | 12470359 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124703593 | 12470359 | Chronic obstructive pulmonary disease | |
| 124703593 | 12470359 | Pyrexia | |
| 124703593 | 12470359 | Supraventricular tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124703593 | 12470359 | 1 | 20160323 | 20160504 | 0 | |
| 124703593 | 12470359 | 2 | 20160518 | 0 | ||
| 124703593 | 12470359 | 3 | 20160323 | 20160504 | 0 | |
| 124703593 | 12470359 | 4 | 20160518 | 0 | ||
| 124703593 | 12470359 | 7 | 20160502 | 20160513 | 0 | |
| 124703593 | 12470359 | 10 | 20160606 | 0 |